SG Americas Securities LLC Has $9.49 Million Stake in Axon Enterprise, Inc $AXON

Key Points

• SG Americas Securities LLC increased its stake in Axon by 301.1% in Q4, holding 16,714 shares after buying 12,547 more, a position valued at approximately $9.49 million.
• Axon beat Q4 estimates with EPS $2.15 versus $1.60 and revenue of $796.7 million (up 38.5% YoY), yet the stock trades at a high P/E of 282.9 and has a 52-week range of $396.41–$885.91.
• Wall Street shows a consensus "Moderate Buy" rating with an average target of $762.93 (16 Buys, 3 Holds); institutional ownership is about 79.08% while insiders sold ~23,855 shares (~$13.3M) in the past three months.

SG Americas Securities LLC raised its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 301.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,714 shares of the biotechnology company's stock after buying an additional 12,547 shares during the period. SG Americas Securities LLC's holdings in Axon Enterprise were worth $9,492,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AXON. Stone House Investment Management LLC bought a new position in shares of Axon Enterprise in the 3rd quarter valued at about $29,000. New Millennium Group LLC bought a new stake in Axon Enterprise during the third quarter worth about $29,000. Root Financial Partners LLC bought a new stake in Axon Enterprise during the third quarter worth about $34,000. Darwin Wealth Management LLC acquired a new position in Axon Enterprise during the second quarter valued at approximately $37,000. Finally, Elevation Point Wealth Partners LLC acquired a new position in Axon Enterprise during the second quarter valued at approximately $56,000. 79.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

AXON has been the subject of several recent research reports. Robert W. Baird set a $800.00 price target on Axon Enterprise in a research report on Wednesday, February 25th. Barclays dropped their price objective on Axon Enterprise from $702.00 to $682.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 25th. Northcoast Research raised Axon Enterprise from a "neutral" rating to a "buy" rating and set a $742.00 price objective for the company in a report on Tuesday, January 6th. Citigroup reissued a "buy" rating on shares of Axon Enterprise in a research note on Wednesday, February 25th. Finally, Royal Bank Of Canada lowered their target price on shares of Axon Enterprise from $860.00 to $735.00 and set an "outperform" rating on the stock in a report on Wednesday, February 25th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $762.93.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $429.94 on Monday. Axon Enterprise, Inc has a 52 week low of $396.41 and a 52 week high of $885.91. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53. The stock has a market capitalization of $34.57 billion, a P/E ratio of 282.86, a PEG ratio of 9.18 and a beta of 1.46. The stock has a 50-day simple moving average of $502.05 and a 200 day simple moving average of $589.77.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The firm had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. During the same quarter in the prior year, the company earned $2.08 earnings per share. The business's revenue for the quarter was up 38.5% compared to the same quarter last year. Analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the completion of the transaction, the insider directly owned 55,588 shares of the company's stock, valued at $29,740,135.88. The trade was a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Erika Nardini sold 198 shares of Axon Enterprise stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total transaction of $100,302.84. Following the transaction, the director directly owned 1,946 shares of the company's stock, valued at approximately $985,804.68. This trade represents a 9.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 23,855 shares of company stock worth $13,299,928 in the last three months. 4.40% of the stock is owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.